We are live on ! Find out more
GYRE icon

Gyre Therapeutics
GYRE

49 hedge funds and large institutions have $75.1M invested in Gyre Therapeutics in 2015 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 12 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,122% more call options, than puts

Call options by funds: $290K | Put options by funds: $9K

13% more capital invested

Capital invested by funds: $66.2M → $75.1M (+$8.86M)

13% less funds holding

Funds holding: 56 → 49 (-7)

50% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 12

70% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 10

Holders
49
Holders Change
-7
Holders Change %
-12.5%
% of All Funds
1.31%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
3
Increased
6
Reduced
12
Closed
10
Calls
$290K
Puts
$9K
Net Calls
+$281K
Net Calls Change
+$53K

Top Buyers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
+$1.22M
2
Deutsche Bank
Deutsche Bank
Germany
+$316K
3
Renaissance Technologies
Renaissance Technologies
New York
+$248K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$221K
5
TDC
Thompson Davis & Co
Virginia
+$37.2K

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Advisers
Two Sigma Advisers
New York
-$446K
2
Two Sigma Investments
Two Sigma Investments
New York
-$361K
3
DS
DRW Securities
Illinois
-$342K
4
NCCM
Nine Chapters Capital Management
New Jersey
-$107K
5
VKH
Virtu KCG Holdings
New York
-$107K
Name Holding Trade Value Shares
Change 		Change in
Stake
SIM
26
Spark Investment Management
New York
$204K -$84.7K -41 -32%
Northern Trust
27
Northern Trust
Illinois
$177K -$6.2K -3 -4%
AA
28
Ancora Advisors
Ohio
$148K – – –
WMSA
29
Weiss Multi-Strategy Advisers
New York
$138K -$22.7K -11 -16%
PPA
30
Parametric Portfolio Associates
Washington
$116K – – –
OA
31
Oak Associates
Ohio
$114K – – –
Bank of America
32
Bank of America
North Carolina
$110K – – –
OAM
33
Oxford Asset Management
United Kingdom
$87K -$8.26K -4 -10%
State Street
34
State Street
Massachusetts
$69K – – –
PAM
35
Panagora Asset Management
Massachusetts
$60K -$16.5K -8 -24%
NCCM
36
Nine Chapters Capital Management
New Jersey
$55K -$107K -52 -68%
TDC
37
Thompson Davis & Co
Virginia
$42K +$37.2K +18 New
Citadel Advisors
38
Citadel Advisors
Florida
$41K -$8.26K -4 -19%
PP
39
PDT Partners
New York
$30K – – –
NFA
40
Nationwide Fund Advisors
Ohio
$28K – – –
BIM
41
BlackRock Investment Management
Delaware
$17K – – –
MA
42
MUFG Americas
New York
$11K +$2.07K +1 +25%
Invesco
43
Invesco
Georgia
$10K – – –
AIG
44
American International Group
New York
$1.49K – – –
GT
45
Glenmede Trust
Pennsylvania
$1K -$2.07K -1 -50%
Creative Planning
46
Creative Planning
Kansas
$1K – – –
JAM
47
Jolley Asset Management
North Carolina
$1K – – –
LTFS
48
Ladenburg Thalmann Financial Services
Florida
$1K – – –
SAM
49
Shamrock Asset Management
Texas
$1K – – –
Simplex Trading
50
Simplex Trading
Illinois
$1K +$2.07K +1 New
1
2
3

GYRE Hedge Fund Activity: Q1 2015 in Review

49 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Gyre Therapeutics (GYRE) for Q1 2015, worth a combined $75.1M — up 13% from $66.2M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of GYRE and 3 opened new positions — a net loss of 7 holders — while 12 trimmed existing stakes and 6 added.

The largest buyer was Avoro Capital Advisors, opening a new position worth an estimated $1.22M. The largest seller was Two Sigma Advisers, exiting entirely with an estimated $446K sold.

  • 49 institutional investors held Gyre Therapeutics (GYRE) as of Q1 2015, down from 56 in Q4 2014.
  • Funds reported $75.1M of Gyre Therapeutics stock for Q1 2015, up 13% quarter-over-quarter.
  • 3 funds opened new Gyre Therapeutics positions in Q1 2015 and 10 closed out, a net change of -7 holders.
  • The largest Gyre Therapeutics buyer in Q1 2015 was Avoro Capital Advisors, an estimated $1.22M added.
  • The largest Gyre Therapeutics seller in Q1 2015 was Two Sigma Advisers, an estimated $446K sold.

Based on aggregated 13F filings for Q1 2015.